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Abstract. We investigated the metabolic stability of four cell penetrating peptides (CPPs), namely SAP,
hCT(9-32)-br, [Pα] and [Pβ], when in contact with either subconfluent HeLa, confluent MDCK or Calu-3
epithelial cell cultures. Additionally, through analysis of their cellular translocation efficiency, we evaluated
possible relations between metabolic stability and translocation efficiency. Metabolic degradation kinetics
and resulting metabolites were assessed using RP-HPLC and MALDI-TOF mass spectrometry.
Translocation efficiencies were determined using fluorescence-activated cell sorting (FACS) and confocal
laser scanning microscopy (CLSM). Between HeLa, MDCK and Calu-3 we found the levels of proteolytic
activities to be highly variable. However, for each peptide, the individual degradation patterns were quite
similar. The metabolic stability of the investigated CPPs was in the order of CF-SAP = CF-hCT(9-32)-br >
[Pβ]−IAF > [Pα] and we identified specific cleavage sites for each of the four peptides. Throughout, we
observed higher translocation efficiencies into HeLa cells as compared to MDCK and Calu-3,
corresponding to the lower state of differentiation of HeLa cell cultures. No direct relation between
metabolic stability and translocation efficiency was found, indicating that metabolic stability in general is
not a main limiting factor for efficient cellular translocation. Nevertheless, translocation of individual CPPs
may be improved by structural modifications aiming at increased metabolic stability.
KEY WORDS: cell penetrating peptides; cellular translocation; epithelial cell cultures; metabolic
cleavage; metabolism kinetics.
INTRODUCTION
The appealing prospects of peptide, protein and nucleic
acid therapeutics has made the delivery of large and
hydrophilic molecules across the plasma membrane into the
cytoplasm and to cellular organelles a vital issue for current
and future drug development. Owing to the barrier properties
of the plasma membrane, the cellular uptake of such
biopolymers is inherently poor, necessitating the development
of efficient delivery vectors. Hence, chemical coupling or
physical assembly of biopolymers of poor cellular accessibility
with so-called cell penetrating peptides (CPPs) has turned
into a prime topic in the biomedical engineering of delivery
systems that are hoped to mediate the non-invasive import of
such therapeutics into cells (1–8).
A major obstacle to CPP mediated drug delivery consists
in the often rapid metabolic clearance of the peptides when in
contact or passing the enzymatic barriers of epithelia and
endothelia (9). Prior to release of the cargo at its destination,
cell penetrating peptides should be sufficiently stable when
carrying the chemically ligated or physically complexed cargo
across the barrier. Nevertheless, information on the enzymatic
stability and degradation of CPP is rare (10–14). For instance,
the stability of pVEC, a CPP derived from murine vascular
endothelial cadherin, was previously assessed by Langel and
coworkers (11,12). pVEC was rapidly degraded when incu-
bated with human aorta endothelial cells and murine A9
fibroblasts. By contrast, when the L-amino-acid residues of its
sequence were replaced by their non-natural D-counterparts,
pVEC was no longer susceptible to degradation, without
losing its translocating properties (12). Another related study
focused on the metabolic stability of the transportan analogue
transportan 10, and penetratin, revealing transportan 10 as
the most, and penetratin as the least, metabolically stable
peptide among the three CPPs (14). Moreover, we analyzed
the metabolic degradation kinetics and the cleavage patterns
of selected CPPs, namely human calcitonin (hCT) derived
peptides, Tat(47-57) and penetratin(43-58) by incubation with
three epithelial models, MDCK, Calu-3 and TR 146 cell
layers (13). The proteolytic activities among the different
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epithelial models and the CPPs were highly variable. Yet the
individual patterns between the three models for the meta-
bolic degradation of each peptide were strikingly similar.
In the present study, we aimed to explore a potential
relationship between the metabolic stability of CPPs and their
translocation capacity. To this end we focused on (1) the
metabolic degradation kinetics and cleavage patterns of four
oligocationic CPPs when in contact with epithelial cell cultures,
and on (2) the efficiency of their cellular uptake. We used
cultures from three epithelial cell lines, HeLa (15), MDCK (16)
and Calu-3 cells (17). The sequences of the four investigated
CPPs are listed in Table I: The first one is the carboxyfluor-
escein (CF) labeled linear proline-rich sweet arrow peptide CF-
SAP, a linear trimer of repetitive VRLPPP domains, and
designed as an amphipathic version of a polyproline sequence
related to γ-zein, a storage protein of maize (18–20). Another
one is a branched modification of the previously reported
linear human calcitonin (hCT) derived CF-hCT(9-32) (21). It is
denoted as CF-hCT(9-32)-br (22) and carries the oligocationic,
SV40 large T antigen in the form of a side-branch to the main
peptide chain. Previous studies revealed that both CF-SAP and
CF-hCT(9-32)-br were non-toxic even in higher concentrations,
and readily translocated into HeLa cells as triggered by
interaction with the negatively charged extracellular matrix,
followed by lipid raft-mediated endocytosis (23). In addition we
investigated two members of the so called MPG family: the
first, [Pβ]-IAF, carrying the C-terminal iodoacetamido-fluores-
cein (IAF) fluorescence marker, combines the hydrophobic
fusion peptide of HIV-1 gp41 and the oligocationic sequence of
SV40 large T antigen. The peptide was originally synthesized
by Vidal et al. (24) and has been previously demonstrated to
deliver oligonucleotides into cultured cells (25). To directly
monitor its cellular uptake, the peptide was C-terminally
labeled with IAF. The second member of the MPG family,
[Pα has been developed through amino acid modifications of
[Pβ] in five positions, aiming at an α-helical structure (20,26).
Because of severe solubility problems with fluorescently
labeled [Pα]-IAF, we studied the metabolism of the non-
labeled peptide only. Deshayes et al.(26) previously reported
about the high affinity of [Pα] for membranes and its secondary
structure required for uptake. The near negligible toxicity of
[Pα] and [Pβ] has been reported by Fernandez et al. (20).
CF-SAP and CF-hCT(9-32)-br demonstrated marked
metabolic stability under all experimental conditions, where-
as, in contrast, [Pα] and [Pβ]-IAF showed drastic enzymatic
degradation, and decomposed quickly even when incubated in
serum free medium. Moreover, we were able to identify specific
cleavage sites for each of the four peptides. Emphasizing the
relevance of the chosen cellular models, we found the uptake
efficiencies of all four CPPs to be strongly cell line dependent.
Interestingly, despite their high enzymatic stability, CF-SAP and
CF-hCT(9-32)-br showed only low extents of translocation into
well differentiated cell layers. This excludes enzymatic degra-
dation to represent a main factor that limits cellular transloca-
tion. Nevertheless, with respect to [Pα] and [Pβ]-IAF improved
stability through structure modification cannot be excluded to
further enhance their performance as CPPs.
MATERIALS AND METHODS
Materials. HeLa and Calu-3 cells were obtained from
American Type Culture Collection ATCC (Rockville, MD,
USA). The MDCK cell line (low resistance, type II) was a gift
from the Biopharmacy group of ETH Zurich (Switzerland)
(27). Cell culture media, trypsin-EDTA, penicillin, strepto-
mycin and Hanks Balanced Salt Solution (HBSS) were from
Gibco (Paisley, USA). Fetal calf serum (FCS) was either
obtained from HyClone (Logan, Utah, USA) or from Fisher
Scientific (Wohlen; Switzerland) and Hoechst 33342 from
Molecular Probes (Leiden, Netherlands). Cell culturing flasks
25 cm2 were from TPP (Trasadingen, Switzerland). Cell
culture inserts (polyethylene terephthalate (PET), 0.4 μm
pore size, 1.6×106 pores per square centimeter, 0.9 cm2
growth area), companion 12 well plates, 24 well plates and
5 ml polypropylene round-bottom tubes (FACS tubes) were
purchased from Falcon (Becton Dickinson Labware, Franklin
Lakes, NJ, USA). Ninety-six well plates and 8 well glass
chamber slides were obtained from Nunc (Roskilde,
Denmark). Aqueous 0.4% Trypan blue solution with 0.81%
sodium chloride and 0.06% potassium phosphate, DMSO and
5(6)-carboxyfluorescein (CF) were purchased from Fluka
(Buchs, Switzerland), and Bradford reagent from Sigma (St.
Louis, MO, USA). α-cyano-4-hydroxy-cinnamic acid was
obtained from Agilent Technologies (Burnsville, Minnesota,
USA), ZipTip from Millipore (Bedford, MA, USA).
Peptides. The investigated CPPs are listed in Table I.
N-terminally CF-labeled sweet arrow peptide, CF-SAP, was
synthesised by solid-phase peptide synthesis on a 2-chlorotrityl
resin following the 9-fluorenyl methoxy carbonyl/tert-butyl
strategy prior to labeling with 5(6)-carboxyfluorescein (19).
The branched human calcitonin (hCT) derived CPP,
N-terminally labeled with 5(6)-carboxyfluorescein (CF),
CF-hCT(9-32)-br, was synthesized by the peptide synthesis
unit of the University of Barcelona (Spain). CF-hCT(9-32)-br
derives from the linear hCT(9-32) CPP (13,21) and was
equipped with the oligocationic SV40 large T antigen in the
side chain of K18 (22). [Pα] and C-terminally 5-(iodoaceta-
Table I. Amino Acid Sequences and Molecular Weights of the Investigated CF and IAF Modified CPPs
Name Sequencea MWb (Da)
CF-SAP CF-VRLPPP-VRLPPP-VRLPPP 2,356
CF-hCT(9-32)-br CF-LGTYTQDFNKFHTFPQTAIGVGAP-NH2 | AFGVGPDEVKRKKKP-NH2 4,606
[Pα] Ac-GALFLAFLAAALSLMGL-WSQ-PKKKRKV-Cya 3,047
[Pα]-IAF Ac-GALFLAFLAAALSLMGL-WSQ-PKKKRKV-Cya-IAF 3,434
[Pβ]-IAF Ac-GALFLGFLGAAGSTMGA-WSQ-PKKKRKV-Cya-IAF 3,296
aBasic aa are indicated in italics
bCalculated molecular weight of the peptides
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mido)-fluorescein (IAF) labeled [Pα], [Pα]-IAF, as well as
C-terminally IAF labeled [Pβ] [Pβ]-IAF, were obtained from
NMI TT GmbH (Reutlingen, Germany). Common structural
elements of [Pα], [Pα]-IAF and [Pβ]-IAF are a non-polar HIV
derived sequence, HIV-1 gp41, and the polar, oligocationic
sequence of SV40 large T antigen, KKKRKV, connected via a
self-fluorescent WSQP spacer (20,24,25,28). Owing to the poor
aqueous solubility of the IAF-labeled [Pα]-IAF, we analyzed its
metabolism kinetics with unlabeled [Pα] which was sufficiently
soluble. However, for FACS and CLSM, which required more
sensitive fluorescence detection, we used [Pα]-IAF expecting
translocation to occur with dissolved peptide only.
Cell Culture. Cells were cultured under standard con-
ditions in 25 cm2 culture flasks at 37°C and 5% CO2. HeLa
and Calu-3 cells were maintained in Dulbecco’s modified
Eagle medium (DMEM), MDCK cells in minimum essential
medium with Earl’ salts (MEM). Media contained 10% heat-
inactivated FCS and 1% penicillin/streptomycin. Each cell
line was used within a range of ten consecutive passage
numbers (HeLa: 9–15; MDCK: 225–235; Calu-3: 36–42).
Confocal Laser Scanning Microscopy (CLSM) of Cellular
Uptake. We estimated the cellular uptake of fluorescently
labeled CPPs by CLSM. HeLa cells were seeded onto eight
well glass chamber slides at a density of 40,000 cells per
square centimeter and were used 1 day after seeding as
exponentially growing, subconfluent cells. MDCK and Calu-3
cells were seeded at a constant density of 20,000 or 50,000
cells per square centimeter, respectively and were used at
day 10 or 16, respectively, as fully confluent monolayers. For
uptake experiments, cells were incubated in 150 μl serum free
medium containing fluorescently labeled CPP or unconjugated
fluorophore at a concentration of 20 μM for 2 h under standard
cell culture conditions. We used 2 mM stock solutions of CPP
or unconjugated fluorophore, respectively, in DMSO that were
further diluted with serum free medium to obtain a final
concentration of 20 μM. For the last 30 min of incubation,
Hoechst 33342 was added for nuclear staining at a final
concentration of 1 μg/ml. Prior to microscopy, cells were rinsed
three times with HBSS buffer and overlaid with HBSS buffer.
To avoid fixation artefacts, we abstained from any fixation of
the samples (29) Additionally, to avoid misinterpretation due
to extracellular fluorescence bound to cell membranes or
working materials, half of the volume was replaced with
aqueous 0.4% Trypan blue solution. Trypan blue is unable to
translocate intact cell membranes which makes it a selective
quencher for extracellularly bound fluorescence (30–32).
Cells were then scanned using a Zeiss CLSM 410 inverted
microscope. Image processing was performed with Imaris, a
3D multi-channel image processing software for confocal
microscope images (Bitplane, Zurich, Switzerland).
As controls, HeLa, MDCK or Calu-3 cells were incubat-
ed with peptide-free medium or with the fluorescence marker
carboxyfluorescein alone (data not shown).
Quantification of CPP Translocation by Fluorescence
Activated Cell Sorting (FACS). We used FACS analysis to
quantify the translocation of fluorescently labeled CPPs. As
with CLSM, HeLa cells were seeded onto 24 well plates at a
density of 40,000 cells per square centimeter and were used
1 day after seeding as exponentially growing cells. MDCK
and Calu-3 cells were seeded at a constant density of 20,000
or 50,000 cells per square centimeter, respectively, and were
used at day 10 or 16, respectively, as fully confluent
monolayers. For uptake experiments, cells were incubated
in 250 μl serum free medium containing fluorescently labeled
CPP or unconjugated fluorophore at a concentration of
20 μM for 2 h under standard cell culture conditions. Prior
to dilution with serum free medium, 2 mM stock solutions of the
respective CPP or unconjugated dye in DMSO were prepared.
After incubation, all cells were extensively washed with PBS
buffer. To cleave adhering CPP from the cell membranes and to
detach the cells from thewell plates, HeLa cells were trypsinized
for 5 min, MDCK and Calu-3 cells for 15 min, as adapted from
the literature (29,33). Cells were then transferred into FACS
tubes and washed once with PBS prior to further analysis. Half
of the volume was replaced with aqueous 0.4% Trypan blue
solution to quench extracellular CPPs (34,35). Cells were
analyzed by FACS on a FacsCalibur (BectonDickinson,
Franklin Lakes, NJ) within 1 h after trypsinization. A total of
8,000 gated cells per sample was counted. Data were analyzed
using Cytomation Summit software (Cytomation Inc., Fort
Collins, USA). As controls, HeLa, MDCK or Calu-3 cells were
incubated with peptide-free medium or with the fluorescence
marker carboxyfluorescein alone (data not shown).
CPP Stability in Serum Free Medium. We used 2 mM
stock solutions of CPPs or unconjugated fluorophore, respec-
tively, in DMSO that were further diluted with serum free
medium to a final concentration of 20 μM. Tightly closed and
protected against light, the tubes were incubated for 21 days
at 37°C under mechanical shaking (150 min−1). Every second
or third day, a sample of 50 μl was withdrawn from each tube
and analyzed by RP-HPLC and MALDI-TOF MS.
MetabolismKinetics of CPP inContactWith Cell Cultures—
RP-HPLC. HeLa and MDCK cells were seeded and cultivat-
ed as described above for FACS studies. Calu-3 cells were
plated onto filter supports at a constant density of 100,000 cells
per square centimeter. After the cells had attached to the filter
overnight, the medium was removed from the apical compart-
ment to allow the monolayer to grow at the air interface. Prior
to metabolic degradation, Calu-3 cells were equilibrated for
30 min at 37°C with serum free medium in order to adjust the
apical side to the experimental conditions. Twenty micromole
of each of the investigated CPPs were dissolved in the
respective medium and added to the apical side. Mechanical
shaking at 150 min−1 was applied to minimize the thickness of
the aqueous boundary layer. Samples of 50 μl were taken from
the apical compartment after 1 and 30 min, and 1, 2, 3, 4, 6 and
8 h incubation for HeLa and MDCK cells, and after 1, 15, 30
and 45 min, and 1, 2, 3, and 8 h incubation for Calu-3
monolayers. As controls, HeLa, MDCK or Calu-3 cells were
incubated with peptide-free medium and samples were taken
as described above. Immediately after taking the samples,
2.5 μl acetic acid (3.7 M) was added in order to stop enzyme
activity (36). Determination of the respective half-lives was by
RP-HPLC. Throughout, we used a Merck-Hitachi RP-HPLC
(VWR International, Dietikon, Switzerland). In order to
improve analytical sensitivity, degradation of CF-SAP, CF-
hCT(9-32)-br and [Pβ]-IAF was monitored by fluorescence
detection of the labels. Accordingly, detection was limited to
intact fluorescently labeled peptides and their N- or C-terminal
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metabolites carrying the N- or C-terminally ligated fluorophore,
respectively. Fluorescence was excitated at 492 nm and detected
at 517 nm. Due to the insufficient solubility of labeled [Pα]-IAF,
unlabeled [Pα] was used for analysis of metabolism kinetics as
the experimental setting did not necessarily require IAF
fluorescence detection. Therefore, we performed UV detection
at 216 nm, and fluorescence detection of tryptophane at 283 nm
for excitation and 350 nm for emission.
RP-HPLC of CPPs was performed as follows: For CF-SAP
we used a linear gradient mobile phase starting at 25% solvent A
consisting ofAcCN/TFA, 99.9:0.1 (v/v) to 25% solvent B (water/
TFA, 99.9:0.1) over 40 min. For CF-hCT(9-32)-br the linear
gradient mobile phase was 30% solvent A to 20% solvent B
over 20 min. In case of [Pα] the linear gradient mobile phase
was 50% solvent A to 0% solvent B over 25 min, and for [Pβ]-
IAF 20% solvent A to 20% solvent B over 40 min. An
analytical RP-18 column with 250×4.6 mm, particle size 5 μm,
pore diameter 300 Å from Vydac (Hesparia, CA, USA) was
applied. The flow rate was 1 ml/min. Peptide concentrations
were calculated from the area under the curve. The data were
empirically evaluated according to pseudo first-order kinetics.
To account for the difference in the cross sectional area
of the cell culture inserts—2 cm2 with HeLa and MDCK cells
versus 0.9 cm2 with Calu-3 cells—the experimental half-lives
were normalized to 1 cm2. This approximation was strictly
limited to the assumption of linear kinetics for the studied
concentration range and excluded any enzyme saturation.
Also all effects of diffusion kinetics were neglected. All
experiments were run in triplicate.
Analysis of Cell Line Specific Protein Content and Cell
Density. The content of protein per well was assessed for
each cell line. For this purpose, seeding conditions of all cell
models such as density and time of growth were kept as
described for the FACS experiments. As described by the
manufacturer, cells were lysed and analyzed using a Bradford
assay in a 96 well plate by measuring the absorption at 595 nm
with a ThermoMax microplate reader (Molecular Device,
Sunnyvale, CA, USA). Standard curves were established using
BSA dissolved in HBSS. Results were normalized to milli-
grams protein per square centimeter cell culture surface.
Cells were counted using a haemocytometer (Assistent,
Sondheim/Rhön, Germany), and the results were converted
into number of cells per square centimeter cell culture
surface. All experiments were performed in triplicate.
Identification of Metabolites Using MALDI-TOF MS.
Metabolites emerging from the degradation of the investigated
CPPs in contact with the cell cultures were identified by matrix
assisted laser desorption ionization time of flight mass spectros-
copy (MALDI-TOF MS) analysis. Samples were directly taken
from cell culture incubates. For this purpose, 1 μl samples
containing CPP and/or metabolites thereof weremixed with 2 μl
of a saturated matrix solution of α-cyano-4-hydroxy-cinnamic
acid. Of this solution, 0.7 μl was applied to the target plate,
allowed to crystallize, and dedusted. CF-SAP, [Pα], and [Pβ]-
IAF were analyzed in reflectron mode, CF-hCT(9-32)-br in
linear mode. Mass acquisition ranged from 750 to 6,000 Da.
External calibration was performed with a peptide mix ranging
between 900 and 1,700 Da. All experiments were performed in
triplicate. For each of the CPPs in contact with either one of the
cell models, one sample per time point was pre-treated in order
to desalt the sample and increase the detection limit and
accuracy using ZipTip according to the manufacturer’s instruc-
tions. Analysis was performed on a MALDI-TOF mass
spectrometer 4700 Proteomics analyzer type AB347000084
Applied Biosystems (Foster City, USA).
RESULTS
Cell Line Dependent Translocation. To investigate a
potential relation between metabolic stability and transloca-
tion efficiency of the CPPs in three epithelial cell lines, we
first determined their efficiency of translocation. HeLa,
MDCK and Calu-3 cell cultures were exposed to either one
of the four cationic CPPs: CF-SAP, CF-hCT(9-32)-br, [Pα]-
IAF and [Pβ]-IAF. Owing to their strong cationic charge, the
CPPs closely sticked to cell membranes rendering direct
interpretation of CLSM data difficult (Fig. 1b). As shown in
Fig. 1c, Trypan blue efficiently quenched extracellular
fluorescence. Therefore, all CLSM studies were strictly
performed under Trypan blue quenching.
After incubation for 2 h at 37°C, there was ready cellular
uptake of all four CPPs in non-confluent, proliferating HeLa
cells (Fig. 2). As shown in Fig. 2, significantly lower amounts
of each of the four CPPs was taken up by the confluent
MDCK layers. CF-SAP and CF-hCT(9-32)-br mainly accu-
mulated in the paracellular space between the cells. Obvious-
ly, paracellular fluorescence was not accessible to Trypan blue
quenching. In the confluent Calu-3 model, none of the four
Fig. 1. Quenching effect through the addition of Trypan blue. MDCK
cells were incubated with [Pβ]-IAF in the absence or in the presence
of Trypan blue and analyzed by FACS (a) and CLSM in the absence
(b) or in the presence (c) of Trypan blue. Cell nuclei (in blue) were
stained with Hoechst 33342. CPPs are displayed in green. Bar=50 μm
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investigated CPPs showed any relevant translocation or
accumulated in the paracellular space. Non-treated cells and
cells incubated with the fluorescence marker carboxyfluor-
escein alone did not show significant intracellular or para-
cellular fluorescence (data not shown).
Quantification of CPP Translocation by FACS Analysis.
For confirmation and quantification of our CLSM findings,
we also tested the extents of translocation by FACS analysis
(Fig. 3). Figure 3a compares the uptake of CF-SAP in the
three different cell models. Similar to CLSM data, confluent
Fig. 2. Translocation of CPPs in epithelial cell models. Each of the cellmodels,HeLa (a, d, g, j), MDCK (b, e, h, k) and Calu-3 (c, f, i, l), was incubated
for 2 h with the investigated CPPs: CF-SAP (a, b, c), CF-hCT(9-32)-br (d, e, f), [Pα]-IAF (g, h, i) or [Pβ]-IAF (j, k, l) and cells were observed by
CLSM. Cell nuclei (displayed in blue) were stained with Hoechst 33342. Bar=50 μm. Translocation of CF-SAP (a) and CF-hCT(9-32)-br (d) in HeLa
was previously reported (23) but added for completeness
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Calu-3 cells showed rather low extents of translocation.
Higher extents were found in confluent MDCK layers, and
highest in non-confluent, proliferating HeLa cells. The cell
model-dependent drop in translocation was the same for all
investigated CPPs (Fig. 2a–d). Throughout, HeLa cells
featured the highest extents of translocation, whereas the
well differentiated and polarized MDCK and Calu-3 layers
showed lower or no relevant uptake. Non-treated cells and
cells incubated with free fluorophore were used as negative
controls. There was no uptake whatsoever into untreated cells
and cells treated with the fluorophore alone. In all studies, we
used Trypan blue quenching to exclude adherent extracellular
fluorescence. As shown in Fig. 1a, a drastic drop in
fluorescence intensity occurred when Trypan blue was added
to the cell suspension prior to FACS analysis.
Peptide Stability in Serum Free Medium. To explore the
chemical stability of the four CPPs over the duration of the
translocation experiments, we performed exploratory chemical
stability studies of all investigated CPPs in the respective
medium without serum. CF-SAP and CF-hCT(9-32)-br showed
good stability over 7 days in serum free medium. After the same
period of time, however, only 70% of [Pβ]-IAF and strikingly
low 18% of [Pα] were detected (data not shown). Thus, with the
exception of [Pα], all compounds demonstrated reasonable or
good chemical stability for metabolism studies of up to 8 h.
Protein Content and Cell Density of Cell Models. As
shown in Table II, the protein contents of the employed cell
models ranged from 1.55±0.13mg/cm2 for HeLa cells to 6.17±
2.2 mg/cm2 for Calu-3 cells. The cell number per square
centimeter was found to be highest for MDCK cells with a
cell density of 520,000 cells per square centimeter and lowest
for HeLa cells with a cell density of 47,083 cells per square
centimeter.
Kinetics of Metabolic Degradation of CPPs in Contact
with Epithelial Cell Cultures. To analyze the susceptibility of
the four CPPs to metabolic degradation as well as to evaluate
contrasts in metabolism kinetics between the investigated cell
lines, we determined the metabolic degradation of CF-SAP,
CF-hCT(9-32)-br, [Pα] and [Pβ]-IAF upon incubation with
HeLa cells, and MDCK and Calu-3 cell layers. Because of
severe solubility problems with fluorescently labeled [Pα] we
used its unlabeled form only. The obtained degradation
profiles of the CPPs were evaluated according to pseudo
first-order degradation kinetics, with the semilogarithmic ln c
versus t graphs showing a linear dependence. The results were
based on three experiments utilizing cells of the same passage
for each combination of peptide and cell line. The half lives
are given in Table III. During the investigated time interval of
8 h, CF-SAP and CF-hCT(9-32)-br were essentially stable in
all cell models. Much shorter half-lives were observed for
Fig. 3. Quantification of translocated CPPs in cell models. Each cell model, HeLa, MDCK and Calu-3, was
incubated for 2 h with the investigated CPPs: CF-SAP, CF-hCT(9-32)-br, [Pα]-IAF or [Pβ]-IAF and
analyzed by FACS analysis. Mean cell fluorescence±SD (n=3)
Table II. Protein contents and Cell Densities in HeLa, MDCK and
Calu-3 Cell Models
Cell line Protein content (mg/cm2)
Cell number per
square centimeter
HeLa 1.55±0.13 47,083±6,166
MDCK 3.03±0.64 520,000±36,055
Calu-3 6.17±2.20 353,333±32,145
Measurements performed on cells seeded and cultured as described
for use in FACS and CLSM experiments. Mean values±SD (n=3) are
given.
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[Pα] and [Pβ]-IAF. For [Pβ]-IAF, cleavage was fastest in the
presence of Calu-3, showing a normalized half-life of about
1 h only; in the presence of both HeLa and MDCK cells the
half-lives were around 5 h. [Pα] showed the fastest degrada-
tion rate, featuring a normalized t1/2 value of only 1 h with
HeLa and MDCK cells, and 0.5 h with Calu-3 cells.
Identification of Metabolites Emerging from CPP Degra-
dation. To identify the typical cleavage sites of the four
investigated CPPs, we analyzed the occurrence of metabolites
and identified the resulting fragments of CF-SAP, CF-hCT(9-
32)-br, [Pα] and [Pβ]-IAF upon incubation with HeLa,
MDCK or Calu-3 cells. Reversed-phase high performance
liquid chromatography (RP-HPLC) and matrix assisted laser
desorption ionization time of flight mass spectrometry
(MALDI-TOF MS) were used for analysis of the samples.
Whereas RP-HPLC revealed the remaining amounts of CPPs
and the levels of their metabolites, MALDI-TOF MS allowed
us to uncover the identity of N- and C-terminal metabolites
(Fig. 4). Using RP-HPLC, only fluorophore-carrying frag-
ments labeled with either N-terminal CF or C-terminal IAF,
respectively, were detectable. Because of the insufficient
solubility of [Pα]-IAF, [Pα] was exclusively used in its better
soluble, unlabeled form. Monitoring was through instrinsic
fluorescence based on tryptophan fluorophores and UV. The
observed m/z values of the MALDI-TOF mass spectra
represent [M+H]+. For control, we analyzed cells incubated
with pure medium solution instead of peptide solution. High
salt concentrations led to low detection limits and high
background noise in MALDI-TOF MS measurements.
Introduction of an additional desalting step using ZipTips
markedly improved the detection sensitivity. Figure 4 shows
two typical MALDI-TOF MS and RP-HPLC spectra, each
after 1 and 120 min, and demonstrates that detection of
metabolites by MALDI-TOF MS and RP-HPLC was
consistent. There was a clear time dependence of degradation.
Only few small metabolite peaks emerged after 1min incubation,
whereas several distinct metabolite peaks were observed after
120min.When incubated with theHeLa,MDCK andCalu-3 cell
cultures, each of the four investigated CPPs degraded into
between three and ten identifiable metabolites. As shown in
Table III. Metabolic Degradation of CF-SAP, CF-hCT(9-32)-br, [Pα]
and [Pβ]-IAF on Different Cell Models Represented as Normalized
Half-Lives
Peptides
Half-life (h)
HeLa MDCK Calu-3
CF-SAP Stable Stable Stable
CF-hCT(9-32)-br Stable Stable Stable
[Pα] 0.94±0.28 0.98±0.08 0.43±0.05
[Pβ]-IAF 5.12±0.56 5.52±0.38 0.99±0.65
Mean±SD (n=3)
Fig. 4. Typical MALDI-TOF MS and RP-HPLC profiles of metabolites upon metabolic
degradation of [Pβ]-IAF in contact with Calu-3 layers. After 1 min, [Pβ]-IAF was
practically fully intact and represented by the main peak corresponding to the original CPP
in the RP-HPLC diagram as well as in the MALDI-TOF MS spectrum. After 2 h of
incubation with Calu-3 cells, the increase in number of metabolite peaks as obtained by
RP-HPLC was consistent with that in the MALDI-TOF MS spectra
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Fig. 5, all three cell cultures yielded mostly identical metabolite
patterns. Due to the high background noise up to 750 Da only
fragments above this mass range were considered. A summary
of expected and measured molecular weights corresponding to
the proposed metabolites is given in Table IV. In these studies,
we considered only frequently occurring peptide fragments.
These are listed in Table IV, with the main fragments indicated
in bold.
Figure 6 schematically illustrates the suggested cleavage
patterns of CF-SAP, CF-hCT(9-32)-br, [Pα] and [Pβ]-IAF in
contact with either one of the cell cultures. For all peptides,
each amino acid (aa) was numbered, including the side chain
of CF-hCT(9-32)-br (aa S1–S15).
CF-SAP. We observed only minor cleavage of CF-SAP, in
terms of both numbers and peak intensities of the metabolites,
corresponding to high stability in contact with HeLa, MDCK
and Calu-3 cell cultures over a time interval of 8 h (Table III).
Nevertheless, some distinct fragments could be revealed, e.g.
with cleavage sites within the first trimer between Arg2 and
Leu3, together with an additional site in the third trimer
between Val13 and Arg14 resulting in the fragment Leu3-Val13
(Table IV and Fig. 6). For this fragment the resulting
counterpart, fragment Arg14-Pro18, was also found. A fre-
quently occurring fragment, Pro4-Pro18, was also found to
result from cleavage in the first trimer between Leu3 and Pro4.
CF-hCT(9-32)-br. Due to its branched character, the
cleavage pattern of CF-hCT(9-32)-br was inherently complex
to evaluate. Clear assignments of distinct fragments were
difficult and made unequivocal identification problematic.
Even more so, the marked stability of this peptide led to
weak intensities of metabolite peaks. Hence, for further
evaluation we only considered a subset of selected and clearly
identifiable fragments. Within the hCT derived backbone of
CF-hCT(9-32)-br, the main cleavage sites were between Gly10
and Thr11, Asp15 and Phe16, and Asn17 and Lys18. In the side
branch, an important cleavage site was found between GlyS5
and ProS6 (Table IV and Fig. 6).
[Pα]. As suggested by its short half-life [Pα] was subject
to fast stepwise cleavage of single amino acids from both the
C- as well as the N-terminus. Two fragments were observed
consistently, namely fragments Ala10-Val27 and Leu3-Leu14
indicating distinct cleavage sites between amino acids Leu3
and Phe4, Ala9 and Ala10, and Leu14 and Met15. Also we
observed cleavage sites in the cationic domain of the
molecule at position Lys23-Lys24 as well as Lys24-Arg25.
[Pβ]-IAF. Corresponding to their analogous sequences,
the degradation patterns of [Pβ]-IAF and [Pα] were similar.
Fig. 5. Identical metabolite patterns of [Pβ]-IAF in all three cell
models. MALDI-TOF MS spectra of [Pβ]-IAF after incubation with
HeLa, MDCK or Calu-3 cell models, respectively, demonstrate
identical metabolite patterns as shown by selected MALDI spectra
within the first hour after incubation
Table IV. Measured Versus Expected Molecular Weights of Metab-
olite Fragments Detected by MALDI-TOF MS
Peptide Fragment Measured MW Calculated MW
CF-SAP CF-18 2,356.3 2,356.9
4–18 1,630.1 1,630.3
3–13 1,182.7 1,182.7
CF-hCT(9-32)-br 11–32 3,977.0 3,976.2
16–25; S14 2,807.6 2,808.8
17–32 3,322.3 3,322.1
18–20; S11 1,587.0 1,586.0
18–22; S5 1,110.4 1,111.0
[Pα] 10–27 1,655.1 1,659.2
3–14 1,250.5 1,250.7
4–23 2,190.2 2,193.9
6–20 1,577.6 1,580.1
5–20 1,691.4 1,693.2
[Pβ]-IAF 1-IAF 3,294.8 3,298.2
5-IAF 2,864.6 2,867.7
7-IAF 2,694.5 2,697.4
17-IAF 1,802.0 1,804.3
23-IAF 1,104.6 1,106.4
24-IAF 976.5 978.2
25-IAF 848.4 850.0
Measured and expected MW values represent [M+H]+. Metabolites
found in all three cell models after approximately 1% to 90%
degradation of the CPPs. Most frequently occurring metabolites are
indicated in italics. S indicates the side chain of CF-hCT(9-32)-br. For
all peptides, each amino acid was numbered, including the side chain
S1–S15 of CF-hCT(9-32)-br
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Important cleavage sites were between Gly6 and Phe7 as well
as between Gly16 and Ala17 and led to the fragments Phe7-
IAF and Leu17-IAF. As similarly observed for [Pα], one of
the peptide’s most frequent fragments, Arg25-IAF, was the
result of a break in the cationic section between position
Lys24 and Arg25, suggesting high susceptibility to enzymatic
degradation in this domain.
DISCUSSION
The aim of the present study was to investigate the
metabolic fate of four CPPs, namely CF-SAP, CF-hCT(9-32)-
br, [Pα], and [Pβ]-IAF, when in contact with three selected
epithelial cell lines. As yet, information on the subjects of
enzymatic stability and degradation of CPPs is rare (10–14).
We also studied the cellular translocation efficiency of the
four peptides into three epithelial cell cultures. To our
knowledge, so far, only few studies scrutinize a relationship
between metabolic stability and translocation efficiency of
CPPs (37,38).
The metabolic clearance of CPPs has several biomedical
aspects: on the one hand, CPPs should be stable enough to
deliver a cargo to its destination prior to be metabolically
cleared (12). On the other hand, metabolic clearance of CPPs
after delivery to its target is desired in order to release the
cargo or a biologically active unit thereof, and avoid systemic
toxicity.
We investigated the metabolic stability of CF-SAP, CF-
hCT(9-32)-br, [Pα], and [Pβ]-IAF in three epithelial cell
cultures with different phenotypes and enzymatic activities,
namely HeLa, MDCK and Calu-3. On surfaces, HeLa cells
grow as proliferating, subconfluent layers with no tight
junctional network. By contrast, MDCK cells develop con-
fluent monolayers forming a continuous sheet of cells joined
by tight junctions (27). Similarly, the airway epithelial cell line
Calu-3 forms polarized and well differentiated monolayers
with tight-junctional networks (39) and, different from
MDCK, generates extracellular mucus (40,41).
Among the four investigated CPPs, CF-SAP and CF-
hCT(9-32)-br were the most stable ones, allowing only minor
rates of metabolic cleavage. Even in contact with Calu-3 cells,
CF-SAP and CF-hCT(9-32)-br were rather stable whereas the
normalized half-lives of intact [Pα] and [Pβ]-IAF were much
shorter. We observed higher protein levels per cm2 for Calu-3
cells as compared to HeLa and MDCK cells. Assuming that
protein and enzyme activity levels correlate, we conclude that
the increased protein levels in Calu-3 layers contribute to the
enhanced metabolism of the four CPPs in this model.
In a former study, we investigated the half-life of the
unbranched CF-hCT(9-32) (13). For this linear peptide, a
half-life of several hours was found when in contact with
MDCK monolayers and less than 1 h with Calu-3 cells.
Through side chain modification of CF-hCT(9-32), resulting
in the branched CF-hCT(9-32)-br, we achieved not only an
Fig. 6. Scheme of suggested metabolic cleavage sites of CPPs upon incubation with the three cell models.
Individually shaded arrowheads correspond to the corresponding cleavage sites between the respective
amino acids. The resulting metabolites are indicated through equally shaded bars as identified by MALDI-
TOF MS
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increase in cellular translocation (23) but also improved
metabolic stability as shown in the present work. Its improved
metabolic stability is concluded to result from efficient steric
hindrance through the introduction of the side chain reaching
out from K18 (Table I). Metabolites of CF-hCT(9-32)-br
occurred in only minor quantities as indicated by small peaks
in the MALDI-TOF MS spectra. Theoretically, metabolic
degradation of the branched CF-hCT(9-32)-br may allow
concurrent cleavage in all three segments of the peptide
which implies a more complex pattern of theoretically
possible fragments as compared to its linear derivative.
Contrasting to the pronounced stability of CF-SAP and
CF-hCT(9-32)-br, cleavage of [Pβ]-IAF was rather quick with
relatively short half-lives ranging from about 1 h in the
presence of Calu-3 cells to about 5 h in the presence of HeLa
and MDCK cells. Among the four investigated CPPs, [Pα]
had the shortest half-life of around 30 min only. Even in
medium alone, i.e. in the absence of any cellular enzyme
activity, [Pα] was subject to fast degradation. Possible
explanations for its non-enzymatic degradation might be (1)
hydrolytic cleavage. Further on, (2) adhesion to cell surfaces
and/or working material (42) and (3) exclusion from analyt-
ical detection by insufficient solubility and aggregation may
occur. In fact, we observed high affinity of [Pα]-IAF to
membrane surfaces. The limited solubilities and aggregation
potential of [Pα]-IAF and [Pβ]-IAF have to be taken into
account for the interpretation of results from uptake and
metabolism studies. Therefore, to avoid misinterpretations,
we focus on the individual relationship of uptake efficiency
and metabolism of each peptide in cultures of the three cell
lines, rather than comparing between the peptides. Structural
differences between [Pβ]-IAF and [Pα] through amino acid
modifications of Gly6, Gly9, Gly12, Thr14 and Ala17 versus
Ala6, Ala9, Leu12, Leu14 and Leu17, respectively, were of no
significant impact on the net chemical stability of the peptides
as indicated by the occurrence of the cleavage sites Gly6-Phe7
and Gly16-Ala17 for [Pβ]-IAF, versus Ala9-Ala10 and Leu14-
Met15 for [Pα]. Furthermore, there was no reduction in the
number of cleavage sites through these modifications. Equal-
ly, the sequence modifications did not have any significant
effect on the efficiency of translocation of these two CPPs in
the investigated cell lines. Altogether, in spite of differences
in extent, there was no major difference in the cleavage
patterns between the three cell lines for each of the
investigated CPPs. This finding is in good agreement with a
former study of our group where we described similar
cleavage patterns for hCT derived CPPs irrespective of the
applied epithelial cell model (13).
In order to assess the impact of metabolic cleavage on
the efficiency of translocation, we tried to estimate the extent
of translocation of CF-SAP, CF-hCT(9-32)-br, [Pα]-IAF and
[Pβ]-IAF. For all investigated CPPs, we observed efficient
uptake in HeLa cells by CLSM and FACS. Corresponding to
its higher state of cellular differentiation, uptake in the
MDCK model was significantly reduced for each of the four
CPPs, and none of the CPPs was observed to translocate
efficiently into confluent Calu-3 cells. Hallbrink et al. (14)
recently suggested that the uptake of cell-penetrating pep-
tides is dependent on the peptide-to-cell ratio. As a consid-
eration of the lack of uptake in MDCK and Calu cells, there
is a relatively much higher number of cells in these experi-
ments as compared with the uptake in HeLa.
Owing to the poor aqueous solubility of the IAF-labeled
[Pα]-IAF, we analyzed its metabolism kinetics with unlabeled
[Pα] whichwas sufficiently soluble.Obviously, this prohibits from
a direct extrapolation of data from [Pα] to [Pα]-IAF. However,
for FACS and CLSM, which required more sensitive fluores-
cence detection, we used [Pα]-IAF expecting translocation to
occur with the available fraction of dissolved peptide only.
CONCLUSION
We demonstrate in the present study that CPP stability
and translocation capacity were strongly cell line dependent,
whereas their cleavage patterns were quite similar between
the three cell cultures. When comparing all four CPPs, there
was no direct relation between metabolic stability and
translocation efficiency indicating that stability is not the
main limiting factor in cellular translocation, at least in the
investigated cell cultures. However, in the context of individ-
ual CPPs, stabilization against chemical as well as enzymatic
degradation may further improve their translocation efficien-
cy. For this purpose, enhanced metabolic CPP stability may
be achieved through replacement of L-amino acids by their
non-physiologic D-counterparts, through N-methylation or
exchange of certain amino acids.
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